THER ADV CHRONIC DIS 润色咨询

Therapeutic Advances in Chronic Disease

出版年份:2010 年文章数:534 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:0.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2023-02-21 naughtyyyy 来自北京

    偏重的研究方向:心血管
    经验分享:投了一个月了,还没找到审稿人,也是醉了...

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2022-05-02 1510122720

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:心血管
    经验分享:比较友好,1月投稿,3月返修,4月底接收

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2023-11-05 ms9000001387813771 来自广东省

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2023-10-25 ms9000001387813771 来自广东省

    7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2023-10-29 ms7000001550259722 来自上海

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:两个月小修接受 很有效率

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2021-12-17 MS9985544

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2022-06-15 ms8000000558825325

    已经第5个审稿人了啊

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2021-12-29 小动量

    同一杂志社不同期刊如何转投(transfer)?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2021-12-29 rayms

    通讯作者最多有多少个?同第一作者最多有多少个?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2115705, encodeId=f9542115e054d, content=偏重的研究方向:心血管<br>经验分享:投了一个月了,还没找到审稿人,也是醉了..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200705/c103783a7e594e719be7741e4f000708/cd994ecd1c9544d1b773484a44f2b724.jpg, createdBy=d2ab5392648, createdName=naughtyyyy, createdTime=Tue Feb 21 13:20:26 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1216199, encodeId=91b81216199bd, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:心血管<br>经验分享:比较友好,1月投稿,3月返修,4月底接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fe44811755, createdName=1510122720, createdTime=Mon May 02 00:06:13 CST 2022, time=2022-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166789, encodeId=e89b2166e899f, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:可能我的稿件质量不够高,它会一直拖着,找不到审稿人,我等了3个月,说找不到审稿人把我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Sun Nov 05 12:29:34 CST 2023, time=2023-11-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2164902, encodeId=5721216490261, content=7月21号投的稿,现在还在编辑那里,为什么这么慢!!!谁能告诉我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0e48720965, createdName=ms9000001387813771, createdTime=Wed Oct 25 19:28:33 CST 2023, time=2023-10-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2165519, encodeId=6d1f2165519bc, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:两个月小修接受 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe6e8107354, createdName=ms7000001550259722, createdTime=Sun Oct 29 11:30:16 CST 2023, time=2023-10-29, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1081349, encodeId=99a61081349b4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:今年投了一篇meta,初审返修1个半月,直到收信确定接受总共历时4个月,对我来说命中概率较高.不知道对你们来说这个算不算快?但是我觉得这个期刊还是很不错,主要是我的文章被接受了,是我写得好还是杂志好?哈哈哈,我觉得这个杂志还是可以考虑的!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS9985544, createdTime=Fri Dec 17 23:07:02 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226559, encodeId=cddb122655915, content=已经第5个审稿人了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14766545849, createdName=ms8000000558825325, createdTime=Wed Jun 15 11:02:27 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107239, encodeId=b3a4110e23915, content=同一杂志社不同期刊如何转投(transfer)?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107240, encodeId=5a48110e240f1, content=通讯作者最多有多少个?同第一作者最多有多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181279, encodeId=a34b21812e914, content=投了3个月,还在邀请审稿人,每天都很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=363b8441284, createdName=ms6000001133190070, createdTime=Sat Jan 13 15:02:21 CST 2024, time=2024-01-13, status=1, ipAttribution=广东省)]
    2024-01-13 ms6000001133190070 来自广东省

    投了3个月,还在邀请审稿人,每天都很焦虑

    0

共45条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分